Tefen Operations Excellence

Publication
Article
BioPharm InternationalBioPharm International-03-01-2004
Volume 17
Issue 3

On March 25, 2004 Centocor will host the first meeting of the European chapter in Leiden, Holland. Wyeth BioPharma and Genzyme have co-sponsored the establishment of this European group; other leading companies - such as Lonza Biologics, Celltech, and Baxter Bioscience - have joined the forum.

On March 25, 2004 Centocor will host the first meeting of the European chapter in Leiden, Holland. Wyeth BioPharma and Genzyme have co-sponsored the establishment of this European group; other leading companies - such as Lonza Biologics, Celltech, and Baxter Bioscience - have joined the forum.

For more information about the consortium and details on future meetings please e-mail us at mailto:excellence@tefen.com.

Articles in this issue
Qualifying Release Laboratories in Europe and the United States
Qualifying Release Laboratories in Europe and the United States
Japan: Discover Asia's Largest and the World's Second Largest Biotechnology Market
Japan: Discover Asia's Largest and the World's Second Largest Biotechnology Market
chart1-87942-1408712593104.jpg
Operations Excellence: BioPharma Consortium Discusses Key Industry Trends
Keeping Biopharmaceutical Cleanrooms Compliant
Keeping Biopharmaceutical Cleanrooms Compliant
Disposable Components Enable a New Approach to Biopharmaceutical Manufacturing
Disposable Components Enable a New Approach to Biopharmaceutical Manufacturing
Tefen Operations Excellence
PennsylvaniaBanner-87211-1408713321314.gif
Site Expansion - Regional Roundup: Pennsylvania
Regulatory Beat: Pharmaceutical Pricing and Healthcare Access Lead Policy Agenda
DelawareBanner-87163-1408713387414.gif
Site Expansion - Regional Roundup: Delaware
Final Word: Beware of Patent Infringement During Discovery Research
StreetTalk: It Takes Two (Or Does It?)
Recent Videos
Christa Myers, CRB Group; Nadiyra Walker Speight, Fujifilm Diosynth Biotechnologies
Laks Pernenkil, PhD, principal and practice leader, US Life Sciences Product & Supply Operations, Deloitte
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

SEKISUI Completes CDMO Capacity Expansion for CGMP Biopharma Manufacturing

Feliza Mirasol
November 19th 2024
Article

Under a £15.7 million (US$20.7 million) investment, SEKISUI has expanded its UK site for clinical-grade drug substance manufacturing.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Alentis Therapeutics Gains $181.4 Million Funding to Advance Anti-Claudin-1 ADCs in Solid Tumors

Feliza Mirasol
November 18th 2024
Article

With financing led by OrbiMed, Novo Holdings, and Jeito Capital, Alentis Therapeutics will develop a pipeline of Claudin-1-targeted ADCs to treat solid tumors.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

FDA Approves PTC Therapeutics’ Gene Therapy for AADC Deficiency

Feliza Mirasol
November 18th 2024
Article

The approval of eladocagene exuparvovec-tneq (Kebilidi) marks the first FDA approval for a gene therapy to treat AADC deficiency.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Lecanemab Gets Nod from CHMP for Use in Early Alzheimer’s Disease

Felicity Thomas
November 15th 2024
Article

Eisai Europe and Biogen have received a positive opinion for the monoclonal antibody therapy to be used as a treatment of adult patients with early Alzheimer’s disease.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Avantor Geared for Biopharma Industry’s Future with Next-Generation Biotherapeutics

Feliza Mirasol
November 14th 2024
Article

Avantor executives discuss the future of the biopharmaceutical industry and the impact that a wave of next-generation biotherapeutics will bring.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Collaboration between Merck and Ginkgo Bioworks for Improving Biologics Manufacturing Achieves First Milestone

Feliza Mirasol
November 12th 2024
Article

Ginkgo Bioworks has achieved the first milestone in an ongoing partnership with Merck, known as MSD outside of the United States and Canada, aimed at improving biologics production.

© 2024 MJH Life Sciences

All rights reserved.